Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Controlled, Randomized, Double-Blinded, Within-Subject, Multicenter, Prospective Clinical Study of TEOSYAL® RHA Global Action and TEOSYAL® RHA Deep Lines Versus Juvéderm® Ultra XC in the Treatment of Moderate to Severe Nasolabial Folds

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02195427
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:56.988087+00:00
Published At
2018-03-26T00:00:00+00:00
Record Updated At
2018-04-25
Results Posted At
2018-03-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Nasolabial Folds, Wrinkles"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-04-25"
protocolSection.identificationModule.nctId
"NCT02195427"
protocolSection.identificationModule.officialTitle
"A Controlled, Randomized, Double-Blinded, Within-Subject, Multicenter, Prospective Clinical Study of TEOSYAL\u00ae RHA Global Action and TEOSYAL\u00ae RHA Deep Lines Versus Juv\u00e9derm\u00ae Ultra XC in the Treatment of Moderate to Severe Nasolabial Folds"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-03-26"

Study condition terms

  • Nasolabial Folds, Wrinkles (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.